Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF

PJP

US46137V6627

Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF Reports Earnings Results for the Half Year Ended October 31, 2018

January 04, 2019 at 08:32 pm

Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF announced earnings results for the half year ended October 31, 2018. For the half year, the company announced total revenue was USD 3.436 million. Net income was USD 43.416 million.

Latest news about Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF

Invesco Exchange-Traded Fund Trust - Invesco Pharmaceuticals ETF Reports Earnings Results for the Half Year Ended October 31, 2023	01-03	CI
Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF Reports Earnings Results for the Full Year Ended April 30, 2023	06/07/23	CI
Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF Reports Earnings Results for the Half Year Ended October 31, 2022	05/01/23	CI
Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals Etf Reports Earnings Results for the Full Year Ended April 30, 2021	08/07/21	CI
Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals Etf Reports Earnings Results for the Full Year Ended April 30, 2020	08/07/20	CI
Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF Reports Earnings Results for the Half Year Ended October 31, 2019	03/01/20	CI
Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF Reports Earnings Results for the Half Year Ended October 31, 2018	04/01/19	CI

Chart Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF

Duration

Period

Chart Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF

More charts

Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.

Sector

Investment Trusts

More about the company

Sector Investment Trusts

	1st Jan change	Capi.
SCOTTISH MORTGAGE INVESTMENT TRUST PLC	+11.51%	15.36B
F&C INVESTMENT TRUST PLC	+6.65%	6.56B
POLAR CAPITAL TECHNOLOGY TRUST PLC	+18.69%	4.73B
ALLIANCE TRUST PLC	+10.97%	4.47B
GREENCOAT UK WIND PLC	-9.50%	4B
JPMORGAN GLOBAL GROWTH & INCOME PLC	+11.33%	3.42B
RIT CAPITAL PARTNERS PLC	-2.23%	3.39B
THE MONKS INVESTMENT TRUST PLC	+11.68%	3.22B
SMITHSON INVESTMENT TRUST PLC	-0.21%	2.88B

Investment Trusts